APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Management Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nuclear Medicine Management Software Market Analysis and Forecast 2026-2032

6 January 2026198 pages

Choose your research edition.

Industry ResearchNuclear Medicine Management Software Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Management Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Management Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Management Software Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Management Software Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Management Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nuclear Medicine Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nuclear Medicine Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nuclear Medicine Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nuclear Medicine Management Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nuclear Medicine Management Software include Mirion Technologies, Comecer, ec2 Software Solutions, Esaote, MIM Software, Mediso, Mirada Medical, LabLogic Systems and GE Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nuclear Medicine Management Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nuclear Medicine Management Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Nuclear Medicine Management Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine Management Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Medicine Management Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Medicine Management Software revenue, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine Management Software Segment by Company

Mirion Technologies

Comecer

ec2 Software Solutions

Esaote

MIM Software

Mediso

Mirada Medical

LabLogic Systems

GE Healthcare

Mozi Healthcare

Nuclear Medicine Management Software Segment by Type

Radiopharmaceutical Management

Image Data Processing

Others

Nuclear Medicine Management Software Segment by Application

Radiopharmaceutical Management

Image Data Processing

Others

Nuclear Medicine Management Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Management Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nuclear Medicine Management Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nuclear Medicine Management Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Management Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine Management Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Radiopharmaceutical Management Major Player Table 3. Image Data Processing Major Player Table 4. Others Major Player Table 5. Global Nuclear Medicine Management Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Radiopharmaceutical Management Major Player Table 7. Image Data Processing Major Player Table 8. Others Major Player Table 9. Nuclear Medicine Management Software Industry Trends Table 10. Nuclear Medicine Management Software Industry Drivers Table 11. Nuclear Medicine Management Software Industry Opportunities and Challenges Table 12. Nuclear Medicine Management Software Industry Restraints Table 13. Global Nuclear Medicine Management Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nuclear Medicine Management Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nuclear Medicine Management Software Market Share by Region (2021-2026) Table 16. Global Nuclear Medicine Management Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nuclear Medicine Management Software Market Share by Region (2027-2032) Table 18. Global Nuclear Medicine Management Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Nuclear Medicine Management Software Revenue Market Share by Players (2021-2026) Table 20. Global Nuclear Medicine Management Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nuclear Medicine Management Software Key Players Headquarters & Area Served Table 22. Global Nuclear Medicine Management Software Players, Product Type & Application Table 23. Global Nuclear Medicine Management Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Nuclear Medicine Management Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Nuclear Medicine Management Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Nuclear Medicine Management Software Revenue Market Share by Type (2021-2026) Table 30. Global Nuclear Medicine Management Software Revenue Market Share by Type (2027-2032) Table 31. Global Nuclear Medicine Management Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Nuclear Medicine Management Software Revenue Market Share by Application (2021-2026) Table 35. Global Nuclear Medicine Management Software Revenue Market Share by Application (2027-2032) Table 36. Mirion Technologies Company Information Table 37. Mirion Technologies Business Overview Table 38. Mirion Technologies Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Mirion Technologies Nuclear Medicine Management Software Product Portfolio Table 40. Mirion Technologies Recent Development Table 41. Comecer Company Information Table 42. Comecer Business Overview Table 43. Comecer Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Comecer Nuclear Medicine Management Software Product Portfolio Table 45. Comecer Recent Development Table 46. ec2 Software Solutions Company Information Table 47. ec2 Software Solutions Business Overview Table 48. ec2 Software Solutions Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ec2 Software Solutions Nuclear Medicine Management Software Product Portfolio Table 50. ec2 Software Solutions Recent Development Table 51. Esaote Company Information Table 52. Esaote Business Overview Table 53. Esaote Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Esaote Nuclear Medicine Management Software Product Portfolio Table 55. Esaote Recent Development Table 56. MIM Software Company Information Table 57. MIM Software Business Overview Table 58. MIM Software Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MIM Software Nuclear Medicine Management Software Product Portfolio Table 60. MIM Software Recent Development Table 61. Mediso Company Information Table 62. Mediso Business Overview Table 63. Mediso Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Mediso Nuclear Medicine Management Software Product Portfolio Table 65. Mediso Recent Development Table 66. Mirada Medical Company Information Table 67. Mirada Medical Business Overview Table 68. Mirada Medical Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Mirada Medical Nuclear Medicine Management Software Product Portfolio Table 70. Mirada Medical Recent Development Table 71. LabLogic Systems Company Information Table 72. LabLogic Systems Business Overview Table 73. LabLogic Systems Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. LabLogic Systems Nuclear Medicine Management Software Product Portfolio Table 75. LabLogic Systems Recent Development Table 76. GE Healthcare Company Information Table 77. GE Healthcare Business Overview Table 78. GE Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GE Healthcare Nuclear Medicine Management Software Product Portfolio Table 80. GE Healthcare Recent Development Table 81. Mozi Healthcare Company Information Table 82. Mozi Healthcare Business Overview Table 83. Mozi Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Mozi Healthcare Nuclear Medicine Management Software Product Portfolio Table 85. Mozi Healthcare Recent Development Table 86. North America Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Nuclear Medicine Management Software Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Nuclear Medicine Management Software Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Nuclear Medicine Management Software Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Nuclear Medicine Management Software Revenue by Country (US$ Million) & (2027-2032) Table 100. China Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 101. China Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 102. China Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 103. China Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Nuclear Medicine Management Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Nuclear Medicine Management Software Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Nuclear Medicine Management Software Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Nuclear Medicine Management Software Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Nuclear Medicine Management Software Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Nuclear Medicine Management Software Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Nuclear Medicine Management Software Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Nuclear Medicine Management Software Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Nuclear Medicine Management Software Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Nuclear Medicine Management Software Image Figure 2. Global Nuclear Medicine Management Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Management Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Radiopharmaceutical Management Image Figure 5. Image Data Processing Image Figure 6. Others Image Figure 7. Global Nuclear Medicine Management Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nuclear Medicine Management Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Radiopharmaceutical Management Image Figure 10. Image Data Processing Image Figure 11. Others Image Figure 12. Global Nuclear Medicine Management Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Nuclear Medicine Management Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nuclear Medicine Management Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Nuclear Medicine Management Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Nuclear Medicine Management Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nuclear Medicine Management Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nuclear Medicine Management Software Revenue Market Share by Type (2021-2032) Figure 20. Global Nuclear Medicine Management Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nuclear Medicine Management Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Nuclear Medicine Management Software Revenue Market Share by Application (2021-2032) Figure 23. North America Nuclear Medicine Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Nuclear Medicine Management Software Revenue Share by Type (2021-2032) Figure 25. North America Nuclear Medicine Management Software Revenue Share by Application (2021-2032) Figure 26. North America Nuclear Medicine Management Software Revenue Share by Country (2021-2032) Figure 27. United States Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Nuclear Medicine Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Nuclear Medicine Management Software Revenue Share by Type (2021-2032) Figure 32. Europe Nuclear Medicine Management Software Revenue Share by Application (2021-2032) Figure 33. Europe Nuclear Medicine Management Software Revenue Share by Country (2021-2032) Figure 34. Germany Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Nuclear Medicine Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Nuclear Medicine Management Software Revenue Share by Type (2021-2032) Figure 44. China Nuclear Medicine Management Software Revenue Share by Application (2021-2032) Figure 45. Asia Nuclear Medicine Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Nuclear Medicine Management Software Revenue Share by Type (2021-2032) Figure 47. Asia Nuclear Medicine Management Software Revenue Share by Application (2021-2032) Figure 48. Asia Nuclear Medicine Management Software Revenue Share by Region (2021-2032) Figure 49. Japan Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Nuclear Medicine Management Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Nuclear Medicine Management Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Nuclear Medicine Management Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Nuclear Medicine Management Software Revenue Share by Country (2021-2032) Figure 59. Brazil Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Nuclear Medicine Management Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Radiopharmaceutical Management
  • Image Data Processing
  • Others
Applications
  • Radiopharmaceutical Management
  • Image Data Processing
  • Others
Companies covered
  • Mirion Technologies
  • Comecer
  • ec2 Software Solutions
  • Esaote
  • MIM Software
  • Mediso
  • Mirada Medical
  • LabLogic Systems
  • GE Healthcare
  • Mozi Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nuclear Medicine Management Software Market by Type
  3. 1.2.1 Global Nuclear Medicine Management Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Radiopharmaceutical Management
  5. 1.2.3 Image Data Processing
  6. 1.2.4 Others
  7. 1.3 Nuclear Medicine Management Software Market by Application
  8. 1.3.1 Global Nuclear Medicine Management Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Radiopharmaceutical Management
  10. 1.3.3 Image Data Processing
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nuclear Medicine Management Software Market Dynamics
  1. 2.1 Nuclear Medicine Management Software Industry Trends
  2. 2.2 Nuclear Medicine Management Software Industry Drivers
  3. 2.3 Nuclear Medicine Management Software Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Management Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nuclear Medicine Management Software Market Perspective (2021-2032)
  2. 3.2 Global Nuclear Medicine Management Software Growth Trends by Region
  3. 3.2.1 Global Nuclear Medicine Management Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nuclear Medicine Management Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Nuclear Medicine Management Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nuclear Medicine Management Software Revenue by Players
  2. 4.1.1 Global Nuclear Medicine Management Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Nuclear Medicine Management Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nuclear Medicine Management Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nuclear Medicine Management Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nuclear Medicine Management Software Key Players Headquarters & Area Served
  7. 4.4 Global Nuclear Medicine Management Software Players, Product Type & Application
  8. 4.5 Global Nuclear Medicine Management Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nuclear Medicine Management Software Market CR5 and HHI
  11. 4.6.3 2025 Nuclear Medicine Management Software Tier 1, Tier 2, and Tier 3
5 Nuclear Medicine Management Software Market Size by Type
  1. 5.1 Global Nuclear Medicine Management Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 5.3 Global Nuclear Medicine Management Software Revenue Market Share by Type (2021-2032)
6 Nuclear Medicine Management Software Market Size by Application
  1. 6.1 Global Nuclear Medicine Management Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nuclear Medicine Management Software Revenue by Application (2021-2032)
  3. 6.3 Global Nuclear Medicine Management Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Mirion Technologies
  2. 7.1.1 Mirion Technologies Company Information
  3. 7.1.2 Mirion Technologies Business Overview
  4. 7.1.3 Mirion Technologies Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Mirion Technologies Nuclear Medicine Management Software Product Portfolio
  6. 7.1.5 Mirion Technologies Recent Developments
  7. 7.2 Comecer
  8. 7.2.1 Comecer Company Information
  9. 7.2.2 Comecer Business Overview
  10. 7.2.3 Comecer Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Comecer Nuclear Medicine Management Software Product Portfolio
  12. 7.2.5 Comecer Recent Developments
  13. 7.3 ec2 Software Solutions
  14. 7.3.1 ec2 Software Solutions Company Information
  15. 7.3.2 ec2 Software Solutions Business Overview
  16. 7.3.3 ec2 Software Solutions Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ec2 Software Solutions Nuclear Medicine Management Software Product Portfolio
  18. 7.3.5 ec2 Software Solutions Recent Developments
  19. 7.4 Esaote
  20. 7.4.1 Esaote Company Information
  21. 7.4.2 Esaote Business Overview
  22. 7.4.3 Esaote Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Esaote Nuclear Medicine Management Software Product Portfolio
  24. 7.4.5 Esaote Recent Developments
  25. 7.5 MIM Software
  26. 7.5.1 MIM Software Company Information
  27. 7.5.2 MIM Software Business Overview
  28. 7.5.3 MIM Software Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MIM Software Nuclear Medicine Management Software Product Portfolio
  30. 7.5.5 MIM Software Recent Developments
  31. 7.6 Mediso
  32. 7.6.1 Mediso Company Information
  33. 7.6.2 Mediso Business Overview
  34. 7.6.3 Mediso Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Mediso Nuclear Medicine Management Software Product Portfolio
  36. 7.6.5 Mediso Recent Developments
  37. 7.7 Mirada Medical
  38. 7.7.1 Mirada Medical Company Information
  39. 7.7.2 Mirada Medical Business Overview
  40. 7.7.3 Mirada Medical Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mirada Medical Nuclear Medicine Management Software Product Portfolio
  42. 7.7.5 Mirada Medical Recent Developments
  43. 7.8 LabLogic Systems
  44. 7.8.1 LabLogic Systems Company Information
  45. 7.8.2 LabLogic Systems Business Overview
  46. 7.8.3 LabLogic Systems Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LabLogic Systems Nuclear Medicine Management Software Product Portfolio
  48. 7.8.5 LabLogic Systems Recent Developments
  49. 7.9 GE Healthcare
  50. 7.9.1 GE Healthcare Company Information
  51. 7.9.2 GE Healthcare Business Overview
  52. 7.9.3 GE Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GE Healthcare Nuclear Medicine Management Software Product Portfolio
  54. 7.9.5 GE Healthcare Recent Developments
  55. 7.10 Mozi Healthcare
  56. 7.10.1 Mozi Healthcare Company Information
  57. 7.10.2 Mozi Healthcare Business Overview
  58. 7.10.3 Mozi Healthcare Nuclear Medicine Management Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Mozi Healthcare Nuclear Medicine Management Software Product Portfolio
  60. 7.10.5 Mozi Healthcare Recent Developments
8 North America
  1. 8.1 North America Nuclear Medicine Management Software Revenue (2021-2032)
  2. 8.2 North America Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Nuclear Medicine Management Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Nuclear Medicine Management Software Revenue by Type (2027-2032)
  5. 8.3 North America Nuclear Medicine Management Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Nuclear Medicine Management Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Nuclear Medicine Management Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Nuclear Medicine Management Software Revenue by Application (2027-2032)
  9. 8.5 North America Nuclear Medicine Management Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Nuclear Medicine Management Software Revenue by Country
  11. 8.6.1 North America Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nuclear Medicine Management Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Nuclear Medicine Management Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nuclear Medicine Management Software Revenue (2021-2032)
  2. 9.2 Europe Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nuclear Medicine Management Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nuclear Medicine Management Software Revenue by Type (2027-2032)
  5. 9.3 Europe Nuclear Medicine Management Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nuclear Medicine Management Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nuclear Medicine Management Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nuclear Medicine Management Software Revenue by Application (2027-2032)
  9. 9.5 Europe Nuclear Medicine Management Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nuclear Medicine Management Software Revenue by Country
  11. 9.6.1 Europe Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nuclear Medicine Management Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nuclear Medicine Management Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nuclear Medicine Management Software Revenue (2021-2032)
  2. 10.2 China Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 10.2.1 China Nuclear Medicine Management Software Revenue by Type (2021-2026)
  4. 10.2.2 China Nuclear Medicine Management Software Revenue by Type (2027-2032)
  5. 10.3 China Nuclear Medicine Management Software Revenue Share by Type (2021-2032)
  6. 10.4 China Nuclear Medicine Management Software Revenue by Application (2021-2032)
  7. 10.4.1 China Nuclear Medicine Management Software Revenue by Application (2021-2026)
  8. 10.4.2 China Nuclear Medicine Management Software Revenue by Application (2027-2032)
  9. 10.5 China Nuclear Medicine Management Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nuclear Medicine Management Software Revenue (2021-2032)
  2. 11.2 Asia Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nuclear Medicine Management Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nuclear Medicine Management Software Revenue by Type (2027-2032)
  5. 11.3 Asia Nuclear Medicine Management Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nuclear Medicine Management Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nuclear Medicine Management Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nuclear Medicine Management Software Revenue by Application (2027-2032)
  9. 11.5 Asia Nuclear Medicine Management Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nuclear Medicine Management Software Revenue by Country
  11. 11.6.1 Asia Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nuclear Medicine Management Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nuclear Medicine Management Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nuclear Medicine Management Software Revenue (2021-2032)
  2. 12.2 SAMEA Nuclear Medicine Management Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nuclear Medicine Management Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nuclear Medicine Management Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nuclear Medicine Management Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nuclear Medicine Management Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nuclear Medicine Management Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nuclear Medicine Management Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nuclear Medicine Management Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nuclear Medicine Management Software Revenue by Country
  11. 12.6.1 SAMEA Nuclear Medicine Management Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nuclear Medicine Management Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nuclear Medicine Management Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst